首页 > 最新文献

Harefuah最新文献

英文 中文
[LISTENING FOR SAFETY].
Pub Date : 2025-01-01
Mayer Brezis

Introduction: Medical errors pose a significant risk to public health. A mistake can often be prevented by timely access to the information that was unnoticed by the decision maker. Communication failure within the team is responsible for most errors that cause patient harm. This article reviews literature on challenges in reducing errors through a culture of listening within the team. A significant barrier to good team communication is fear of speaking up. According to surveys in the USA and Israel, nearly a third of the staff testified to fear reporting something that could endanger a patient. The difficulty of expressing oneself freely prevents the correction of failures and causes burnout at work. Improved communication is related to psychological safety in the organizational culture: the leader demonstrates humility, curiosity and gratitude towards the opinions of the team members and makes sure that no one gets hurt if they express an idea, question, concern or report a mistake. Training juniors and seniors by providing tools to improve communication within the team may be useful and can be facilitated through a simulation-based workshop. The challenge of listening to prevent disasters was learned in a tragic way at the National Aeronautics and Space Administration (NASA), and more recently, in Israel when repeated ominous warnings were ignored before the October 7th monstrous terror attack. Respectful listening is an essential key to cooperation and success in society in general and health organizations in particular.

{"title":"[LISTENING FOR SAFETY].","authors":"Mayer Brezis","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Medical errors pose a significant risk to public health. A mistake can often be prevented by timely access to the information that was unnoticed by the decision maker. Communication failure within the team is responsible for most errors that cause patient harm. This article reviews literature on challenges in reducing errors through a culture of listening within the team. A significant barrier to good team communication is fear of speaking up. According to surveys in the USA and Israel, nearly a third of the staff testified to fear reporting something that could endanger a patient. The difficulty of expressing oneself freely prevents the correction of failures and causes burnout at work. Improved communication is related to psychological safety in the organizational culture: the leader demonstrates humility, curiosity and gratitude towards the opinions of the team members and makes sure that no one gets hurt if they express an idea, question, concern or report a mistake. Training juniors and seniors by providing tools to improve communication within the team may be useful and can be facilitated through a simulation-based workshop. The challenge of listening to prevent disasters was learned in a tragic way at the National Aeronautics and Space Administration (NASA), and more recently, in Israel when repeated ominous warnings were ignored before the October 7th monstrous terror attack. Respectful listening is an essential key to cooperation and success in society in general and health organizations in particular.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"164 1","pages":"51-55"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[KERATOCONUS: DIAGNOSIS AND INNOVATIONS].
Pub Date : 2025-01-01
Nir Erdinest, Dror Ben Ephraim-Noyman, Or Shmueli, David Landau, Itay Lavy, Abraham Solomon

Introduction: The importance of early detection of keratoconus lies in early treatment to prevent complications resulting from disease progression and in planning optimal follow-up or screening schedules for family members, considering the genetic component of the disease. In the past, with the absence of accessible, adequate imaging technology such as corneal topography to detect subtle manifestations of the disease, keratoconus was considered rare. This resulted in later detection when the disease had progressed to a more advanced, severe state, with many patients requiring corneal transplants. Currently, early detection can have significant consequences because of the possibility of early intervention, such as corneal cross-linking‏, which slows disease progression. Early detection of mild ectatic changes in the cornea is essential when screening candidates for refractive surgery to prevent postsurgical ectasia. In recent years, the detection of keratoconus has focused on the molecular level, such as identifying inflammatory biomarkers, and in corneal imaging. The progress in corneal imaging technology now provides detailed imaging of the epithelial and Bowman layers, which augment the ability to detect minimal changes, revealing disease development at a very early stage. Analyzing anterior corneal high-order aberrations also assists in identifying keratoconus. Corneal biomechanics evaluation likewise contributes to early keratoconus diagnosis. The latest frontier in keratoconus diagnosis is employing artificial intelligence, which has been combined in the past few years with corneal imaging devices. The following review will focus on the most current developments concerning keratoconus diagnosis, concentrating on the most novel tools and strategies.

导言:早期发现角膜塑形镜的重要性在于及早治疗,以防止疾病发展引起并发症,并考虑到该疾病的遗传因素,为家庭成员制定最佳的随访或筛查计划。过去,由于缺乏方便、适当的成像技术(如角膜地形图)来检测疾病的细微表现,角膜炎被认为是罕见的。这导致患者在疾病发展到晚期、严重程度时才被发现,许多患者需要接受角膜移植手术。目前,早期发现可产生重大影响,因为有可能进行早期干预,如角膜交联术,从而减缓疾病的发展。在筛选屈光手术候选者时,早期发现角膜的轻度异位变化以防止术后角膜异位至关重要。近年来,角膜病的检测主要集中在分子水平(如确定炎症生物标志物)和角膜成像方面。角膜成像技术的进步现在可以提供上皮层和鲍曼层的详细成像,从而增强了检测微小变化的能力,在早期阶段就能发现疾病的发展。分析角膜前部高阶像差也有助于识别角膜炎。角膜生物力学评估同样有助于早期角膜炎诊断。人工智能是角膜病诊断的最新前沿技术,在过去几年中已与角膜成像设备相结合。下面的综述将重点介绍有关角膜病诊断的最新进展,集中于最新颖的工具和策略。
{"title":"[KERATOCONUS: DIAGNOSIS AND INNOVATIONS].","authors":"Nir Erdinest, Dror Ben Ephraim-Noyman, Or Shmueli, David Landau, Itay Lavy, Abraham Solomon","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The importance of early detection of keratoconus lies in early treatment to prevent complications resulting from disease progression and in planning optimal follow-up or screening schedules for family members, considering the genetic component of the disease. In the past, with the absence of accessible, adequate imaging technology such as corneal topography to detect subtle manifestations of the disease, keratoconus was considered rare. This resulted in later detection when the disease had progressed to a more advanced, severe state, with many patients requiring corneal transplants. Currently, early detection can have significant consequences because of the possibility of early intervention, such as corneal cross-linking‏, which slows disease progression. Early detection of mild ectatic changes in the cornea is essential when screening candidates for refractive surgery to prevent postsurgical ectasia. In recent years, the detection of keratoconus has focused on the molecular level, such as identifying inflammatory biomarkers, and in corneal imaging. The progress in corneal imaging technology now provides detailed imaging of the epithelial and Bowman layers, which augment the ability to detect minimal changes, revealing disease development at a very early stage. Analyzing anterior corneal high-order aberrations also assists in identifying keratoconus. Corneal biomechanics evaluation likewise contributes to early keratoconus diagnosis. The latest frontier in keratoconus diagnosis is employing artificial intelligence, which has been combined in the past few years with corneal imaging devices. The following review will focus on the most current developments concerning keratoconus diagnosis, concentrating on the most novel tools and strategies.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"164 1","pages":"39-45"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[MAIGNE'S THORACOLUMBAR JUNCTION SYNDROME]. [maigne 's胸腰椎交界综合征]。
Pub Date : 2024-12-01
Atzmon Tsur, Avi Ohry

Introduction: The characteristic of thoracolumbar junction syndrome (TLJS( described by Maigne are pain in the iliac crest and tenderness on palpation at the level of the junction between the lower dorsal and the upper lumbar vertebra. It is an often unrecognized and treatable cause of low back pain. TLJS is commonly associated with those who have low back pain, although it does not always present pain in this region. The source of the pain may be due to a disorder, which affects the nerves in the thoracolumbar junction of the spine, but presents usually in the lower abdomen, around the pelvic region, and in the groin. However, while the majority of the stress may be borne by the facet joints between T12 and L1, in reality, any spinal joints between T9 and L2 have the potential to develop lesions and nerve impingements, increasing the risk of referred pain. Lumbar vertebrae are not suited to rotation or twisting like the thoracic vertebrae, are making the site susceptible to problems. Patients with Maigne's syndrome generally respond well to manual techniques. In addition, therapeutic exercises for the spine, anti-inflammatory and analgesic drugs, and nerve block can improve functional outcome.

简介:Maigne描述的胸腰节综合征(TLJS)的特征是髂嵴疼痛和触诊下背和上腰椎交界处的压痛。这是一种经常被忽视和治疗的下腰痛的原因。TLJS通常与腰痛相关,尽管并不总是在该区域出现疼痛。疼痛的来源可能是由于一种疾病,这种疾病影响脊柱胸腰段连接处的神经,但通常出现在下腹部、骨盆周围和腹股沟。然而,虽然大部分压力可能由T12和L1之间的小关节承受,但实际上,T9和L2之间的任何脊柱关节都有可能发生病变和神经撞击,增加了牵涉性疼痛的风险。腰椎不适合像胸椎那样旋转或扭曲,都使该部位容易出现问题。Maigne综合征患者通常对手工手法反应良好。此外,脊柱的治疗性锻炼、抗炎镇痛药物和神经阻滞可以改善功能结果。
{"title":"[MAIGNE'S THORACOLUMBAR JUNCTION SYNDROME].","authors":"Atzmon Tsur, Avi Ohry","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The characteristic of thoracolumbar junction syndrome (TLJS( described by Maigne are pain in the iliac crest and tenderness on palpation at the level of the junction between the lower dorsal and the upper lumbar vertebra. It is an often unrecognized and treatable cause of low back pain. TLJS is commonly associated with those who have low back pain, although it does not always present pain in this region. The source of the pain may be due to a disorder, which affects the nerves in the thoracolumbar junction of the spine, but presents usually in the lower abdomen, around the pelvic region, and in the groin. However, while the majority of the stress may be borne by the facet joints between T12 and L1, in reality, any spinal joints between T9 and L2 have the potential to develop lesions and nerve impingements, increasing the risk of referred pain. Lumbar vertebrae are not suited to rotation or twisting like the thoracic vertebrae, are making the site susceptible to problems. Patients with Maigne's syndrome generally respond well to manual techniques. In addition, therapeutic exercises for the spine, anti-inflammatory and analgesic drugs, and nerve block can improve functional outcome.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"728-731"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[THE SURGICAL INTELLIGENCE REVOLUTION - APPLYING AI TO IMPROVE SURGICAL QUALITY AND SAFETY]. 【手术智能革命——应用人工智能提高手术质量和安全性】。
Pub Date : 2024-12-01
Yuval Mirkin, Dotan Asselman, Sari Maril, Michal Guindy, Tamir Wolf

Introduction: The use of artificial intelligence (AI) in medicine is rising fast. We continually hear about novel AI-based technologies being deployed to aid clinical teams in areas like interpreting medical images, understanding pathology, determining diagnosis, predicting prognosis, and deciding on interventions. The field of surgery, however, has been slower to jump on the AI bandwagon. In this paper, we present Surgical Intelligence, an innovative and fast-developing field involving routine capture and AI-based analysis of endoscopic procedure videos. We discuss the need for documenting surgical video, the potential benefits for training and quality improvement, and the features that allow Surgical Intelligence platforms to provide accessible and effective solutions for medical teams.

导读:人工智能(AI)在医学中的应用正在快速增长。我们不断听到新的基于人工智能的技术被用于帮助临床团队在解释医学图像、理解病理、确定诊断、预测预后和决定干预等领域。然而,外科领域在加入人工智能的潮流方面一直比较慢。在本文中,我们介绍了外科智能,这是一个创新和快速发展的领域,涉及常规捕获和基于人工智能的内镜手术视频分析。我们讨论了记录手术视频的需求,培训和质量改进的潜在好处,以及允许外科智能平台为医疗团队提供可访问和有效解决方案的功能。
{"title":"[THE SURGICAL INTELLIGENCE REVOLUTION - APPLYING AI TO IMPROVE SURGICAL QUALITY AND SAFETY].","authors":"Yuval Mirkin, Dotan Asselman, Sari Maril, Michal Guindy, Tamir Wolf","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The use of artificial intelligence (AI) in medicine is rising fast. We continually hear about novel AI-based technologies being deployed to aid clinical teams in areas like interpreting medical images, understanding pathology, determining diagnosis, predicting prognosis, and deciding on interventions. The field of surgery, however, has been slower to jump on the AI bandwagon. In this paper, we present Surgical Intelligence, an innovative and fast-developing field involving routine capture and AI-based analysis of endoscopic procedure videos. We discuss the need for documenting surgical video, the potential benefits for training and quality improvement, and the features that allow Surgical Intelligence platforms to provide accessible and effective solutions for medical teams.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"687-690"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Books Review: A Family of Heroes, OUTLIVE, Literature and medicine in German literature between the two world wars]. [书评:《英雄家族》、《活得长久》、《两次世界大战期间德国文学中的文学与医学》]。
Pub Date : 2024-12-01
Bilha Paryente, Yehuda Shoenfeld, Mordechai Ravid

Introduction: Books Review: A Family of Heroes, OUTLIVE, Literature and medicine in German literature between the two world wars.

导读:书评:《英雄家族》、《活得更久》、《文学与医学》在两次世界大战之间的德国文学。
{"title":"[Books Review: A Family of Heroes, OUTLIVE, Literature and medicine in German literature between the two world wars].","authors":"Bilha Paryente, Yehuda Shoenfeld, Mordechai Ravid","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Books Review: A Family of Heroes, OUTLIVE, Literature and medicine in German literature between the two world wars.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"734-737"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[EOSINOPHILIC ESOPHAGITIS: MUCH MORE IS UNKNOWN YET THAN DISCOVERED]. [嗜酸性粒细胞食管炎:未知的比发现的多得多]。
Pub Date : 2024-12-01
Jawad Hindy, Zahava Vadasz, Tova Rainis

Introduction: Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus, which is mediated by Th2 cells that could start at any age, from early childhood to adulthood. The pathogenesis of the disease is not fully understood, but apparently it consists of a combined interaction between hereditary and environmental factors. Over the years, EoE has become an increasingly diagnosed disease in the context of esophageal symptoms. Nowadays, it is considered the second most common cause of chronic esophagitis and dysphagia (after GERD which is the leading cause on the list). The hallmark of the disease is the presence of eosinophils in the esophageal mucosa (> 15 eosinophil/HPF). Clinically, EoE is characterized by various esophageal symptoms, ranging from mild dysphagia to complications that eventually appear, including esophageal food impaction which usually requires urgent endoscopic removal. Long term complications occur as a result of a defective remodeling process of the inflamed esophagus, which includes histological changes of fibrosis, angiogenesis, and smooth muscle hypertrophy. Due to its progressive course, treatment of the disease requires a close and long-term managerial and therapeutic strategy. There are currently a variety of treatment options for the disease depending on its degree and severity, starting with dietary treatment, pharmacological therapy and ending with esophageal dilations if necessary.

嗜酸性食管炎(EoE)是一种由Th2细胞介导的食管慢性炎症性疾病,可在任何年龄开始,从幼儿到成年。该病的发病机制尚不完全清楚,但显然是遗传和环境因素共同作用的结果。多年来,EoE已成为一种越来越多的食管症状诊断疾病。如今,它被认为是慢性食管炎和吞咽困难的第二大常见原因(排在反流之后,反流是最主要的原因)。本病的标志是食管黏膜出现嗜酸性粒细胞(bbb150eosinophill /HPF)。临床上,EoE以各种食管症状为特征,从轻微的吞咽困难到最终出现的并发症,包括食管食物嵌塞,通常需要紧急内镜切除。长期的并发症是由于发炎的食道重塑过程的缺陷,包括纤维化、血管生成和平滑肌肥大的组织学改变。由于其进行性病程,该病的治疗需要一个密切和长期的管理和治疗策略。根据疾病的程度和严重程度,目前有多种治疗选择,从饮食治疗开始,药物治疗,必要时以食管扩张结束。
{"title":"[EOSINOPHILIC ESOPHAGITIS: MUCH MORE IS UNKNOWN YET THAN DISCOVERED].","authors":"Jawad Hindy, Zahava Vadasz, Tova Rainis","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus, which is mediated by Th2 cells that could start at any age, from early childhood to adulthood. The pathogenesis of the disease is not fully understood, but apparently it consists of a combined interaction between hereditary and environmental factors. Over the years, EoE has become an increasingly diagnosed disease in the context of esophageal symptoms. Nowadays, it is considered the second most common cause of chronic esophagitis and dysphagia (after GERD which is the leading cause on the list). The hallmark of the disease is the presence of eosinophils in the esophageal mucosa (> 15 eosinophil/HPF). Clinically, EoE is characterized by various esophageal symptoms, ranging from mild dysphagia to complications that eventually appear, including esophageal food impaction which usually requires urgent endoscopic removal. Long term complications occur as a result of a defective remodeling process of the inflamed esophagus, which includes histological changes of fibrosis, angiogenesis, and smooth muscle hypertrophy. Due to its progressive course, treatment of the disease requires a close and long-term managerial and therapeutic strategy. There are currently a variety of treatment options for the disease depending on its degree and severity, starting with dietary treatment, pharmacological therapy and ending with esophageal dilations if necessary.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"710-716"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Letters to Editor: The risk for clinically significant copy number variants in pregnancies with two soft markers, Geriatriophobia - a new concept in the medical world in Israel]. [致编辑的信:有两个软标记的妊娠中临床显著拷贝数变异的风险,老年恐惧症——以色列医学界的一个新概念]。
Pub Date : 2024-12-01
Gustavo Malinger, Amihood Singer, Julia Grinshpun-Cohen, Lena Sagi-Dain, Eliyahu Hayim Mizrahi

Introduction: Letters to Editor: The risk for clinically significant copy number variants in pregnancies with two soft markers, Geriatriophobia - a new concept in the medical world in Israel.

导论:致编辑的信:在怀孕有两个软标记的临床显著拷贝数变异的风险,老年恐惧症-在以色列医学界的一个新概念。
{"title":"[Letters to Editor: The risk for clinically significant copy number variants in pregnancies with two soft markers, Geriatriophobia - a new concept in the medical world in Israel].","authors":"Gustavo Malinger, Amihood Singer, Julia Grinshpun-Cohen, Lena Sagi-Dain, Eliyahu Hayim Mizrahi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Letters to Editor: The risk for clinically significant copy number variants in pregnancies with two soft markers, Geriatriophobia - a new concept in the medical world in Israel.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"738-740"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A 38 YEARS-OLD YOUNG MALE WITH CHEST PAIN AND ECG CHANGES]. [38岁年轻男性,胸痛,心电图改变]。
Pub Date : 2024-12-01
Mohammad Haydar, Roy Bezalel, Uriel Levinger

Introduction: Coronary vasospasm is a well-known condition causing acute chest syndrome and can lead to myocardial infarction, ventricular arrhythmias, and even sudden cardiac death. While there are extensive case series showing the association of coronary vasospasm with drugs like cocaine, the association of marijuana with coronary vasospasm has not been reported frequently. When smoked, marijuana results in a rapid, dose-dependent tachycardia, an increase in blood pressure, and an increase in cardiac output. This in turn leads to increased oxygen demand, which is augmented by the vasoconstriction endothelial damage by smoking and activation of cannabinoid receptor 1 ( CB1) by marijuana. We presented a case of a 38-year-old young male who was admitted with chest pain, ST elevation in electrocardiogram (ECG) and normal coronary arteries at cardiac catheterization and a positive Acetylcholine Provocation test. With the legalization of marijuana and medical cannabis in certain states, marijuana-related hospitalizations and Emergency Room visits are likely to increase. It is therefore important for clinicians to know the various effects of marijuana, especially potentially fatal ones like coronary vasospasm. This case illustrates the importance of recognition of vasospasm in patients taking marijuana .Physicians should consider this in their differential diagnosis of patients presenting with chest pain and history of cannabis use.

简介:冠状血管痉挛是一种众所周知的引起急性胸综合征的疾病,可导致心肌梗死、室性心律失常,甚至心源性猝死。虽然有大量的病例系列表明冠状血管痉挛与可卡因等药物有关,但大麻与冠状血管痉挛的关系并没有经常被报道。当吸食大麻时,会导致快速的、剂量依赖性的心动过速、血压升高和心输出量增加。这反过来又导致需氧量增加,这是由吸烟血管收缩内皮损伤和大麻素受体1 (CB1)的激活而增加的。我们报告了一个38岁的年轻男性病例,他因胸痛,心电图ST段抬高,心导管检查冠状动脉正常,乙酰胆碱激发试验阳性而入院。随着大麻和医用大麻在某些州的合法化,与大麻有关的住院治疗和急诊室就诊可能会增加。因此,对临床医生来说,了解大麻的各种影响,尤其是潜在的致命影响,如冠状动脉痉挛,是很重要的。本病例说明了在吸食大麻的患者中识别血管痉挛的重要性。医生在诊断胸痛和有大麻使用史的患者时应考虑到这一点。
{"title":"[A 38 YEARS-OLD YOUNG MALE WITH CHEST PAIN AND ECG CHANGES].","authors":"Mohammad Haydar, Roy Bezalel, Uriel Levinger","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Coronary vasospasm is a well-known condition causing acute chest syndrome and can lead to myocardial infarction, ventricular arrhythmias, and even sudden cardiac death. While there are extensive case series showing the association of coronary vasospasm with drugs like cocaine, the association of marijuana with coronary vasospasm has not been reported frequently. When smoked, marijuana results in a rapid, dose-dependent tachycardia, an increase in blood pressure, and an increase in cardiac output. This in turn leads to increased oxygen demand, which is augmented by the vasoconstriction endothelial damage by smoking and activation of cannabinoid receptor 1 ( CB1) by marijuana. We presented a case of a 38-year-old young male who was admitted with chest pain, ST elevation in electrocardiogram (ECG) and normal coronary arteries at cardiac catheterization and a positive Acetylcholine Provocation test. With the legalization of marijuana and medical cannabis in certain states, marijuana-related hospitalizations and Emergency Room visits are likely to increase. It is therefore important for clinicians to know the various effects of marijuana, especially potentially fatal ones like coronary vasospasm. This case illustrates the importance of recognition of vasospasm in patients taking marijuana .Physicians should consider this in their differential diagnosis of patients presenting with chest pain and history of cannabis use.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"705-708"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[RIGHT HEART FAILURE PRESENTATION OF IDIOPATHIC MASSIVE PULMONARY EMBOLISM - CASE REPORT]. [特发性大面积肺栓塞的右心衰竭表现--病例报告]。
Pub Date : 2024-12-01
Doron Menachemi, Margarita Fraimovitch, Roberto Ainbinder, Miriam Judith Ginzburg

Introduction: Massive pulmonary embolism (PE) is a life threatening condition with age-related escalation in prevalence. Acute PE is a common and sometimes fatal disease. The approach to the evaluation should be efficient while simultaneously avoiding the risks of unnecessary testing so that therapy can be promptly initiated and potential morbidity and mortality avoided. The imminent condition might lead to obstructive shock with acute right heart failure and eventually to rapid hemodynamic deterioration and death. At a younger age, massive PE causes death very rapidly in one third of the cases. During one year, follow-up of death in the presence of right heart failure is three times higher than those without it. About half of PE cases, are idiopathic and occur without acquired risk factors such as antecedent trauma, surgery, immobilization, or diagnosis of cancer. Unlike provoked PE (pPE) with acquired risk factors, idiopathic PE (iPE) is less likely to be predicted or prevented. Failure to accurately and promptly diagnose and treat deep vein thrombosis (DVT) and PE can result in excess morbidity and mortality due to post thrombotic syndrome, pulmonary hypertension, and recurrent thrombosis. Chest pain and shortness of breath are chief complaints frequently evaluated in the emergency department. Younger patients tend to have benign presentations, and often leave with diagnoses of self-limiting diseases or etiologies that are easily treated in the emergency department. The presenting clinical signs and symptoms should illuminate the primary physician to this life-threatening condition leading to fast diagnosis and prompt lifesaving treatment. At the end of the primary treatment, we need to assess and address each patient for the likelihood of thromboembolism recurrence, which will be highest among those patients with idiopathic events or those with cancer-associated thrombosis. We favor prolonged anticoagulation in these scenarios. In addition, we strongly advocate periodic scheduled follow-up of patients on long-term anticoagulation for secondary prophylaxis to re-evaluate their bleeding and recurrence risk. In practice, initial treatment of deep venous thrombosis and pulmonary embolism should be based on low molecular weight heparin (LMWH) in patients without renal failure. Thrombolytic agents may be useful in case of massive pulmonary embolism, but more evaluation is needed. Bleeding and heparin thrombocytopenia are the main adverse effects of these treatments.

大规模肺栓塞(PE)是一种危及生命的疾病,其患病率与年龄相关。急性肺心病是一种常见且有时致命的疾病。评估的方法应该是有效的,同时避免不必要的检测风险,以便及时开始治疗,避免潜在的发病率和死亡率。这种迫在眉睫的状况可能导致阻塞性休克并急性右心衰,最终导致血液动力学迅速恶化和死亡。在年轻的时候,三分之一的病例中,大量PE会导致死亡。在一年的随访中,右心衰患者的死亡率是无右心衰患者的三倍。大约一半的PE病例是特发性的,没有获得性危险因素,如先前的创伤、手术、固定或癌症诊断。与具有获得性风险因素的诱发性PE (pPE)不同,特发性PE (iPE)不太可能被预测或预防。如果不能准确、及时地诊断和治疗深静脉血栓形成(DVT)和PE,可能会导致血栓形成后综合征、肺动脉高压和复发性血栓形成所导致的过高的发病率和死亡率。胸痛和呼吸短促是急诊科经常评估的主诉。年轻的患者往往有良性的表现,往往离开诊断自限性疾病或病因,很容易在急诊室治疗。呈现的临床体征和症状应该使主治医生了解这种危及生命的疾病,从而快速诊断和及时治疗。在初级治疗结束时,我们需要评估和处理每个患者的血栓栓塞复发的可能性,这在特发性事件或癌症相关血栓形成的患者中是最高的。在这种情况下,我们倾向于延长抗凝时间。此外,我们强烈建议定期随访长期抗凝二级预防患者,以重新评估其出血和复发风险。在实践中,对于没有肾功能衰竭的患者,深静脉血栓和肺栓塞的初始治疗应以低分子肝素(LMWH)为基础。溶栓剂在大面积肺栓塞的情况下可能有用,但需要更多的评估。出血和肝素性血小板减少症是这些治疗的主要副作用。
{"title":"[RIGHT HEART FAILURE PRESENTATION OF IDIOPATHIC MASSIVE PULMONARY EMBOLISM - CASE REPORT].","authors":"Doron Menachemi, Margarita Fraimovitch, Roberto Ainbinder, Miriam Judith Ginzburg","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Massive pulmonary embolism (PE) is a life threatening condition with age-related escalation in prevalence. Acute PE is a common and sometimes fatal disease. The approach to the evaluation should be efficient while simultaneously avoiding the risks of unnecessary testing so that therapy can be promptly initiated and potential morbidity and mortality avoided. The imminent condition might lead to obstructive shock with acute right heart failure and eventually to rapid hemodynamic deterioration and death. At a younger age, massive PE causes death very rapidly in one third of the cases. During one year, follow-up of death in the presence of right heart failure is three times higher than those without it. About half of PE cases, are idiopathic and occur without acquired risk factors such as antecedent trauma, surgery, immobilization, or diagnosis of cancer. Unlike provoked PE (pPE) with acquired risk factors, idiopathic PE (iPE) is less likely to be predicted or prevented. Failure to accurately and promptly diagnose and treat deep vein thrombosis (DVT) and PE can result in excess morbidity and mortality due to post thrombotic syndrome, pulmonary hypertension, and recurrent thrombosis. Chest pain and shortness of breath are chief complaints frequently evaluated in the emergency department. Younger patients tend to have benign presentations, and often leave with diagnoses of self-limiting diseases or etiologies that are easily treated in the emergency department. The presenting clinical signs and symptoms should illuminate the primary physician to this life-threatening condition leading to fast diagnosis and prompt lifesaving treatment. At the end of the primary treatment, we need to assess and address each patient for the likelihood of thromboembolism recurrence, which will be highest among those patients with idiopathic events or those with cancer-associated thrombosis. We favor prolonged anticoagulation in these scenarios. In addition, we strongly advocate periodic scheduled follow-up of patients on long-term anticoagulation for secondary prophylaxis to re-evaluate their bleeding and recurrence risk. In practice, initial treatment of deep venous thrombosis and pulmonary embolism should be based on low molecular weight heparin (LMWH) in patients without renal failure. Thrombolytic agents may be useful in case of massive pulmonary embolism, but more evaluation is needed. Bleeding and heparin thrombocytopenia are the main adverse effects of these treatments.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"695-698"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[EFFECTIVENESS OF SERIAL C-REACTIVE PROTEIN (CRP) MEASUREMENTS IN HOSPITALIZED PATIENTS WITH BLOOD STREAM INFECTION]. [系列c反应蛋白(crp)测量在血流感染住院患者中的有效性]。
Pub Date : 2024-12-01
Yuval Schwartz, Aviv Hanuka, Tali Bdolah-Abram, Marc V Assous, Amos M Yinnon, Gavriel Munter

Background: C-reactive protein (CRP) is increasingly being used as an inflammatory marker in sepsis. Its main use is for diagnosis, less for prognosis, while it is increasingly used for serial monitoring of response to treatment - with little evidence to support this practice.

Objectives: Assessment of the effectiveness of serial measurements of CRP in the management of patients with blood stream infection (BSI).

Methods: This was a retrospective study of two patient cohorts, one in 2015 (cohort A) and the other in 2018 (cohort B), each included 200 consecutively diagnosed patients with proven BSI. We assessed the following outcome markers: antibiotic management, duration of admission and in-hospital mortality.

Results: Baseline demographic and clinical data of the cohorts were similar. In cohort A, a single CRP test was obtained from 5% of the patients, while in cohort B, 95% of patients had CRP tests with a mean of 5.7 tests/person. Empiric, appropriate antibiotic treatment, increased from 72% in cohort A to 75% in cohort B (NS). Duration of antibiotic treatment did not change (10±8 days). The in-hospital mortality rate decreased from 38.5% in cohort A to 30.5% in cohort B (NS), as did mortality <7 days after diagnosis of BSI, from 17.5% to 14% respectively (NS).

Conclusions: We found statistically insignificant differences between the cohorts. In our view there is currently no solid evidence to support the serial use of CRP tests in the management of patients with BSI.

背景:c反应蛋白(CRP)越来越多地被用作脓毒症的炎症标志物。它的主要用途是诊断,较少用于预后,同时越来越多地用于对治疗反应的连续监测——几乎没有证据支持这种做法。目的:评价CRP系列测量在血流感染(BSI)患者管理中的有效性。方法:对2015年(队列a)和2018年(队列B)两个患者队列进行回顾性研究,每个队列包括200例连续诊断的确诊BSI患者。我们评估了以下结局指标:抗生素管理、住院时间和住院死亡率。结果:队列的基线人口学和临床资料相似。在队列A中,5%的患者进行了一次CRP检测,而在队列B中,95%的患者进行了CRP检测,平均5.7次/人。经验,适当的抗生素治疗,从队列A的72%增加到队列B的75% (NS)。抗生素治疗时间无变化(10±8天)。住院死亡率从队列A的38.5%下降到队列B (NS)的30.5%,死亡率也下降了。结论:我们发现队列之间的统计学差异不显著。在我们看来,目前没有确凿的证据支持在BSI患者的管理中连续使用CRP检测。
{"title":"[EFFECTIVENESS OF SERIAL C-REACTIVE PROTEIN (CRP) MEASUREMENTS IN HOSPITALIZED PATIENTS WITH BLOOD STREAM INFECTION].","authors":"Yuval Schwartz, Aviv Hanuka, Tali Bdolah-Abram, Marc V Assous, Amos M Yinnon, Gavriel Munter","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>C-reactive protein (CRP) is increasingly being used as an inflammatory marker in sepsis. Its main use is for diagnosis, less for prognosis, while it is increasingly used for serial monitoring of response to treatment - with little evidence to support this practice.</p><p><strong>Objectives: </strong>Assessment of the effectiveness of serial measurements of CRP in the management of patients with blood stream infection (BSI).</p><p><strong>Methods: </strong>This was a retrospective study of two patient cohorts, one in 2015 (cohort A) and the other in 2018 (cohort B), each included 200 consecutively diagnosed patients with proven BSI. We assessed the following outcome markers: antibiotic management, duration of admission and in-hospital mortality.</p><p><strong>Results: </strong>Baseline demographic and clinical data of the cohorts were similar. In cohort A, a single CRP test was obtained from 5% of the patients, while in cohort B, 95% of patients had CRP tests with a mean of 5.7 tests/person. Empiric, appropriate antibiotic treatment, increased from 72% in cohort A to 75% in cohort B (NS). Duration of antibiotic treatment did not change (10±8 days). The in-hospital mortality rate decreased from 38.5% in cohort A to 30.5% in cohort B (NS), as did mortality <7 days after diagnosis of BSI, from 17.5% to 14% respectively (NS).</p><p><strong>Conclusions: </strong>We found statistically insignificant differences between the cohorts. In our view there is currently no solid evidence to support the serial use of CRP tests in the management of patients with BSI.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 11","pages":"699-704"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Harefuah
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1